生物标志物 生物标志物
Jean Marques Brizola1, Chiara Maria Righini1, Carlos Alberto Buchpiguel1
1University of São Paulo Medical School, São Paulo, São Paulo, Brazil.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
大麻素 (CBD) 显示出减轻阿尔茨海默氏症患者与年龄相关的神经炎症的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物医学成像技术 生物医学成像技术
背景情况:
- 大麻素 (CBD) 具有已知的抗炎和神经保护性质.
- 临床前研究表明,CBD可能会延迟或预防神经退行性疾病,如阿尔茨海默氏症 (AD).
- 这项研究调查了CBD在老化过程中对AD动物模型的影响.
研究的目的:
- 评估CBD在阿尔茨海默病 (AD) 的老年动物模型中的治疗潜力.
- 评估CBD对大脑新陈代谢和神经炎症的影响,使用正子发射断层扫描 (PET).
- 在衰老和AD的背景下,探索CBD治疗反应的性别特异性差异.
主要方法:
- 雄性和雌性3xTg-AD小鼠被给予CBD (20 mg/kg) 或载体30天.
- pozitron发射断层扫描 (PET) 成像 ([18F]FDG和[11C]PK11195) 用于测量不同年龄段的大脑新陈代谢和神经炎症.
- 行为测试 (新的物体识别和高加迷宫) 评估了认知功能和焦虑.
主要成果:
- 在车辆和CBD治疗组中观察到大脑代谢 ([18F]FDG吸收) 的显著性别差异.
- 似乎CBD治疗在雄性小鼠中增加了大脑代谢,并在老年雌性小鼠中部分缓解了代谢减少.
- PET成像检测到衰老诱导的变化比行为评估更敏感,对神经炎症标志物没有显著的性别影响 ([11C]PK11195).
结论:
- 这项研究强调了3xTg-AD模型中老化期间大脑新陈代谢中的突出性别差异.
- 通过减轻与年龄相关的神经炎症事件,CBD显示出潜在的神经保护作用.
- 在这种AD模型中,PET成像是评估与衰老相关的大脑变化的敏感工具,其表现优于行为测试.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516